Tuhura Biosciences, INC./NV (HURA) — 10-Q Filings
All 10-Q filings from Tuhura Biosciences, INC./NV. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (3)
-
TuHURA's Losses Widen Amid Kineta Merger, Phase 3 Trial Launch
— Aug 14, 2025 Risk: high
TuHURA Biosciences, Inc. reported a significant increase in net loss for the six months ended June 30, 2025, reaching $16,188,206, up from $10,107,377 in the pr -
TuHURA Biosciences Files Q1 2025 10-Q
— May 15, 2025 Risk: medium
TuHURA Biosciences, Inc. filed a 10-Q for the period ending March 31, 2025. The company, formerly known as Kintara Therapeutics, Inc., is incorporated in Nevada -
TuHURA Biosciences 10-Q: Merger, Warrants, and Preferred Stock
— Nov 14, 2024 Risk: medium
TuHURA Biosciences, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial performance and business activities, inc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX